Janux Therapeutics, Inc. (JANX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.00B | -5.6% |
| 2024 | $1.06B | +179.0% |
| 2023 | $380.41M | +4.5% |
| 2022 | $364.01M | -4.2% |
| 2021 | $379.82M | +2242.1% |
| 2020 | $16.22M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.00B | -5.6% |
| 2024 | $1.06B | +179.0% |
| 2023 | $380.41M | +4.5% |
| 2022 | $364.01M | -4.2% |
| 2021 | $379.82M | +2242.1% |
| 2020 | $16.22M | — |